Research | Volume 38, Article 194, 22 Feb 2021 | 10.11604/pamj.2021.38.194.27124

Immunisation program reviews in East and Southern Africa. 2012-2018; key lessons

Messeret Eshetu Shibeshi, Balcha Girma Masresha, Fussum Daniel

Corresponding author: Messeret Eshetu Shibeshi, World Health Organisation, Inter-Country Support Team for East and Southern Africa, Harare, Zimbabwe

Received: 24 Nov 2020 - Accepted: 05 Feb 2021 - Published: 22 Feb 2021

Domain: Health information system management,Immunization

Keywords: Africa, immunization, program review, EPI review, vaccine preventable diseases, data quality, hesitancy

©Messeret Eshetu Shibeshi et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite this article: Messeret Eshetu Shibeshi et al. Immunisation program reviews in East and Southern Africa. 2012-2018; key lessons. Pan African Medical Journal. 2021;38:194. [doi: 10.11604/pamj.2021.38.194.27124]

Available online at: https://www.panafrican-med-journal.com/content/article/38/194/full

Home | Volume 38 | Article number 194

Research

Immunisation program reviews in East and Southern Africa. 2012-2018; key lessons

Immunisation program reviews in East and Southern Africa. 2012-2018; key lessons

Messeret Eshetu Shibeshi1,&, Balcha Girma Masresha2, Fussum Daniel1

 

1World Health Organisation, Inter-Country Support Team for East and Southern Africa, Harare, Zimbabwe, 2World Health Organisation, Regional Office for Africa, Brazzaville, Congo

 

 

&Corresponding author
Messeret Eshetu Shibeshi, World Health Organisation, Inter-Country Support Team for East and Southern Africa, Harare, Zimbabwe

 

 

Abstract

Introduction: The World Health Organisation (WHO) recommends that countries conduct comprehensive national immunisation program reviews regularly to help them identify systems wide-barriers or gaps and monitor performance against the set targets.

 

Methods: we reviewed reports from the latest national immunisation program reviews conducted in the 20 countries in the sub-region in the course of 2012-2018. We generated descriptive analysis of the findings across the sub-region.

 

Results: the 20 program reviews included field observations to the subnational levels as well as interviews with program staff and stakeholders. At the time of the reviews, only 11 countries had functional National Immunisation Technical Advisory Groups. Operational funding was inadequate in half of the countries. The reviews documented the cancellation of outreach services, supportive supervision visits and maintenance of cold chain equipment due to the lack of fuel or operational funding. Immunisation programs in 10 countries had major human resource gaps. Vaccine stock management tools were not effectively used in 10 countries, and stock out of vaccines and supplies was documented in 9 countries during the review. The full components of the RED strategy were implemented in only 3 of the 20 countries. Twelve countries reported challenges with the availability and accuracy of target populations. Four countries had documented the presence of vaccine hesitant groups at the time of the reviews.

 

Conclusion: the reviews demonstrated challenges in various aspects of the programs in different countries. The implementation of the review recommendations should be built into the annual program plans, as well as into coasted multi-year plans, in order to address the gaps and helps the program to attain the set targets. With the rapid evolution of the scope and complexity of the immunisation programs in recent years, countries should invest their efforts in building the capacity of their human resources as well as updating their logistics and data systems.

 

 

Introduction    Down

In May 2012, the World Health Assembly (WHA) endorsed the Global Vaccine Action Plan (GVAP) [1]. The World Health Organisation (WHO) African Region adopted a seven-year immunisation strategic plan (2014-2020) aligned to the GVAP [2]. Countries in the region have developed and are implementing national strategic and annual action plans following the principles and targets of the GVAP and the regional strategic plans. To determine progress towards the set milestones and targets, and to align program activities, countries regularly monitor vaccination coverage, disease trends and other programmatic indicators at national and subnational levels. As part of the effort to strengthen the governance and leadership of national immunisation programs, countries are expected to establish organs including the National Immunization Technical Advisory Group (NITAG) comprised of independent technical experts responsible for generating evidence-based policy guidance and technical recommendations; the Inter-Agency Coordinating Committee (ICC) which brings the national authorities together with the various donors and technical partners, and is a platform for endorsing program plans, advocating and mobilizing resources; and the National Regulatory Authority (NRA) that ensures the appropriate registration of safe and quality vaccines for use in the country [3-5].

 

On the operational aspects, WHO advises countries to implement the Reaching Every District (RED) approach to be able to reach all communities and all children, including those who normally do not access health services, and thus to assure equity in immunisation service delivery. The RED approach comprises of establishing outreach services; conducting regular supportive supervision; linking services with communities; monitoring and using data for action; and the management of resources [6]. The monitoring of vaccination service delivery data is done by recording the number of doses of antigen delivered in each health facility and aggregating it at the district, provincial and national levels. Administrative coverage is calculated by dividing the number of doses provided by the target population (the number of surviving infants for the calendar year) for the particular catchment area. The target population is generated from census data or from projections made based on recent census data. Considering the challenge with the accuracy of numerator and denominator information, WHO and United Nations Childrens Fund (UNICEF) generate annual estimates of coverage for each antigen for each member state using the provided administrative data, information from coverage surveys, logistics information and other programmatic data. These WHO estimates are only generated for the national level [7]. Data quality assessments are conducted regularly to assist countries to identify challenges with the data management system and be able to troubleshoot using the data quality [8].

 

The World Health Organisation (WHO) recommends the periodic conduct of comprehensive national immunisation Program reviews (EPI reviews) to help countries identify system-wide barriers or gaps, monitor performance against the set targets, and develop strategic direction to remove these barriers or gaps towards the development of a more robust and resilient program [9]. These program reviews, conducted every 4 to 5 years, constitute a holistic assessment of the strengths and weaknesses of the immunisation program at national, sub-national and service-delivery levels. The reviews are done with the participation of various technical partners and provide the evidence to align the immunisation program´s strategic directions and priority activities which are then translated into comprehensive Multi Year Plans (cYMP), and subsequent annual program plans, and as advocacy tools to reinforce the engagement of the leadership within the respective Ministries of Health [9,10]. Countries supported with Global Alliance for Vaccines and Immunisation (GAVI) funding undertake annual joint appraisal exercises with a focus on grant monitoring and overall progress towards program goals. These appraisals do not substitute for comprehensive program reviews [11].

 

The Eastern and Southern African sub-region of the WHO consists of 20 member states, a subset of the 47-member State of the WHO African region. These countries are Botswana, Comoros, Eritrea, Eswatini, Ethiopia, Lesotho, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Rwanda, Seychelles, South Africa, South Sudan, Tanzania, Uganda, Zambia, and Zimbabwe. Between the years 2014 - 2018, all of the twenty countries in the sub-region conducted at least one comprehensive immunisation program review. This manuscript attempts to summarize the strengths and weaknesses of the immunisation programs in the countries in the sub-region, as documented in the program reviews, with a view to highlight actions required for countries to progress towards the programmatic targets.

 

 

Methods Up    Down

Comprehensive immunisation Program Reviews are cross-sectional program assessments that are conducted through the review of documents and data, the interview of immunisation program staff at national and subnational levels, as well as field visits to provinces, districts and to service delivery sites. The data from the program review is collected using standardized data collection tools developed by WHO AFRO, which are adapted to the individual country context. The tool includes sections that cover the following thematic areas: (i) leadership, governance and coordination; (ii) human resource management, capacity building and supervision (iii) vaccine supply quality, logistics and cold chain; (iv) service delivery; (v) data monitoring, immunisation quality and vaccine preventable diseases surveillance; (vi) demand generation, social mobilization and advocacy. At the end of a program review, the findings and the recommendations are compiled by the review team in a formal report and presented to the respective Ministry of Health. We reviewed the detailed narrative technical reports generated from each of the national immunisation program reviews conducted in the 20 countries in the sub-region in the course of 2014-2018. We conducted a descriptive analysis of the findings from the review exercises and attempted to do a summary of the findings by thematic areas.

 

 

Results Up    Down

Each of the 20 countries conducted at one national immunisation program review between 2012 and 2018 (Table 1). These 20 program reviews included field observations to a total of 137 Regions, 314 districts and 718 health facilities. In addition, the reviews included interviews with 475program staff and stakeholders from the national levels,1,028 immunisation session observations, and also exit interviews with 1,435 care-givers. The field observations included verification of the existence of relevant plans, guidelines and tools, as well as supervision of immunisation services delivery, cold chain and vaccine management practices. The major findings from these reviews are summarized below.

 

Leadership, governance and coordination: at the time of the program reviews, 16 of the countries (80%) had some sort of legislation promoting immunisation, and 13(65%) had updated immunisation policy documents. All except one country had updated comprehensive multi-year plans for Immunisation (cMYPs). Full government financing of the immunisation program was documented in the 6 countries while 14 countries (which were GAVI eligible) depended on complementary support from partners such as Gavi for new and underutilized vaccines and UNICEF for the purchase of traditional vaccines. Immunisation services were provided free of charge in public health institutions in all countries. In the area of coordination, only 11 countries had functional National Immunisation Technical Advisory Groups (NITAG), while 17 countries had National Regulatory Authorities (NRA) at the time of the review. The 6 self-financing countries did not have functioning Inter-Agency Coordination committees (ICC), while in 10 of the remaining 14 countries; the ICC was playing a key role in the coordination of partner support to the national immunisation program. The level of coordination between the immunisation program and the unit responsible for disease surveillance was limited in 8 of the 20 countries. Operational funding was inadequate in half of the countries in the sub-region. The reviews documented the cancellation of outreach services as well as the regular conduct of supportive supervision and maintenance of cold chain capacity at sub national level in these countries, mainly related to the lack of fuel or funds to rent vehicles.

 

Human resources management, capacity building and supportive supervision: ten (50%) countries had gaps in the number of staff and the skill mix required to run an efficient immunisation program at national and sub-national levels. These countries also lacked clear terms of reference or job descriptions for the assigned focal persons who were engaged in the day-to-day management of the immunisation program at different levels. Seventeen countries (85%) had clear plans for program supervision. However, supervisory visits to the subnational levels were inadequate or irregular in 4 of these 17 countries, due to limitations in funding and means of transport. Standardized tools for the supervision of immunisation services were available in only 14 of the 20 countries.

 

Vaccine and cold chain logistics: vaccine stock management tools were not effectively used in 10 (50%) countries, with tools lacking or outdated or not used regularly to monitor vaccine stocks at the health facility levels. Stock out of vaccines and supplies at the sub national level, lasting more than 3 months, was documented in 9 (45.0%) countries during the review. It was documented that 4 countries had frequent power interruptions and inadequate backup generators. Five countries did not have an updated cold chain equipment inventory system and no cold chain rehabilitation /replacement plan at the time of the review. The cold chain capacity was considered inadequate according to the reviews in 4 countries mainly at the sub national level (Table 2).

 

Service delivery: the full components of the RED Strategy were implemented in only 3 of the 20 countries (15%). At the time of the reviews, 14 countries (70%) did not have up-to-date operational level micro-plans for routine immunisation services. In addition,9 (45.0%) countries were not able to organize outreach services as planned due to transport and field staff constraints. Five (25.0%) countries also did not have enough cold chain equipment to run outreach services. At the time of the reviews, three countries had not yet introduced AD syringes for use in their immunisation programs. Defaulter tracing mechanisms were available in only 12 (60%) countries (Table 3).

 

Coverage monitoring, disease surveillance and data quality: the availability and accuracy of target populations has been reported as a major challenge in 12 (60.0%) out of the 20 countries. Besides, the review in ten countries detected gaps in the systematic use of data for decision making, especially at the district and Health Facility levels, linked mostly due to knowledge gaps and limited resources. Data quality review and data harmonization meetings were held regularly in 13 (65%) countries. Seven countries reported major challenges with their monitoring systems. These included denominators projected from outdated census causing significant over or under-estimation of the real target population, too many monitoring tools, discrepancies in the data across different administrative levels, as well as limited time and capacity to analyze and use data for decision making (Table 4). The reviews in 10 of the countries also documented gaps among health workers in the basic knowledge required to run effective surveillance systems. These included gaps in the understanding of standard case definitions for priority conditions, the core performance indicators for the surveillance of vaccine preventable disease and the various epidemiological concepts in use in the surveillance system. All except one country had annual VPD surveillance plans at the time of the review. National expert committees for Adverse Events Following Immunisation (AEFI) were in place in 16 countries [Table 5].

 

Demand generation and social mobilization: fifteen countries had a communication strategy for the immunisation program. A written plan to address crisis/risk communication was available in 17 (85.0%) countries. In 5 countries, it was noted that communication efforts were well developed for new vaccines introduction and supplemental immunisation activities (SIA) but quite weak in promoting routine immunisation and community surveillance. Four countries had documented the presence of vaccine hesitant groups at the time of the reviews. Four (20%) of the 20 countries did not have communication messages tailored to address specific groups.

 

 

Discussion Up    Down

The findings in this summary have been aggregated and no specific country detail is given, since the main objective of the study was to demonstrate the challenges countries face in general. Moreover, since the reviews took place in the years 2012-2018, it is expected that any gaps have been addressed by the specific countries following the review exercise. While 12 of the 20 reviews were conducted in the last 5 years, 40% were conducted more than 5 years ago indicating the need for timely program reviews to steer the programs in the right direction. Immunisation program reviews cover a broad scope of program area but may not always achieve the necessary depth given the limited time allocated to the exercise [8,9] When in-depth reviews are needed, countries utilize the focused review tools that cover specific program areas which may include vaccine management practices, new vaccine introduction process and outcomes, surveillance performance, data quality or others [9,12].

 

The 20 program reviews covered in this study indicated that some countries did not have any legislation or policy framework for immunisation. Having the appropriate legislative framework helps countries to protect national immunisation budgets and also to address community demand for vaccines [13]. Similarly, the lack of functioning and vibrant Inter-agency Coordinating Committees may affect the coordination of activities among the partners as well as the effective mobilization of resources. Effective oversight and coordination of immunisation programs by government and partners are critical to achieving national immunisation goals. National coordination forums, including ICCs and health sector coordinating committees play an essential role in this work [14]. The growing complexity of the immunisation area of work in the last two decades requires the presence of strong human resources with the necessary managerial skills and tools. Findings from the reviews show that half of the countries were experiencing limitations in their human resource capacity within the national program and at sub-national levels. Health worker training plays an important role in improving overall performance including vaccination coverage [15,16]. Other studies and program reviews have also shown the critical role of human resource in immunisation program delivery [17-19].

 

In the 20 program reviews in this sub-region, capacity gaps are also reflected in the lack of clear managerial tools (e.g, terms of reference, job descriptions and standard orientation/training for newly assigned focal persons). Inadequate supportive supervision and the absence of standard supervisory tools are other common challenges. Supportive supervision has been shown to be an important component in immunisation programs[20,21]. Regarding vaccine management logistics, half of the countries in the sub-region were not using the standard stock management tools, which are critical for monitoring stock levels, vaccine utilization, vaccine wastage, and forecasting needs. The reported stockouts of vaccine and supplies in nearly half of the countries in this review are important from the point of view of the missed opportunities for the respective antigens the gaps created. The finding is comparable to the study that documented 38% countries in sub-Saharan Africa experienced at least one national-level stockout event for at least one vaccine and for at least one month during 2015 [22].

 

In a study focused at the district level in 3 African countries, LaFond et al. have identified six common drivers of routine immunisation coverage improvement. These include the presence of a cadre of community-centered health workers, health system and community partnership, regular review of health workers performance, the delivery of immunisation services tailored to community needs, political commitment to routine immunisation, and the actions of development partners. The study claimed that the presence of all six factors together was found to have positive impact in terms of coverage improvements [23]. The finding from the 20 national immunisation program reviews indicated that not all of these enabling components of good quality immunisation program performance were being implemented at district level in some of the countries. It is well known that service factors and parental attitudes and knowledge are some of the most important reasons for non-vaccination. Among the service factors, Favin et al. have found that geographic inaccessibility of services, vaccine stock-outs and/or cold chain problems accounted for the majority of missed opportunities for the vaccination of children in many countries [24]. A lot of challenges exist with regards to immunisation data monitoring and quality in the African region. This review has identified the main challenges including knowledge gaps, discrepancies in data at different levels, and weak capacity to use data for decision making. Some of the root causes of challenges in monitoring systems include the lack of sustainable resources for immunisation, logistical limitations, and the lack of reliable denominator data for planning and coverage monitoring [25].

 

The reviews documented serious gaps in the surveillance for vaccine preventable diseases (VPDs) related to limited knowledge of health workers, inadequate resources and programmatic focus. Gaps were documented in the prioritization for active surveillance, as well as in the monitoring and use of surveillance data, as reported in other studies in the African region [26,27]. The presence of population groups hesitant towards vaccination documented in 4 countries is a growing challenge that has in the past contributed to disease outbreaks [28,29]. Noting the complexity of vaccine hesitancy and the limited evidence available on how it can be addressed, identified strategies should be carefully tailored according to the target population, their reasons for hesitancy, and the specific context [30].

 

Limitations of the study: these national immunisation program reviews were conducted using similar approaches and tools, but the review was conducted by different teams, and using tools adopted for the national context. This may result in differences in the formulation of the review questions and interpretation of data. During these reviews, the sampling of subnational units was done purposively to strike a balance between urban and rural districts as well as strong performing and weaker districts. Therefore, all the results may not be comparable across the countries. In addition, it is expected that the countries will have acted upon the review findings and made the necessary program changes since the reviews, and so the results may not reflect the current situation at country level at the time of publication.

 

 

Conclusion Up    Down
The national immunisation program reviews in the sub-region have been useful tools to identify barriers or program gaps and generate recommendations for the national program and local partners to address the barriers or gaps. The reviews in the subregion have demonstrated challenges with regards to various aspects of the programs in different countries and unless addressed they will fail short to ensure provision of equitable immunisation service delivery. The follow up of recommendations to address the challenges and gaps constitutes an essential component of the review exercise aiming to enable them to attain the set targets. Countries should invest in continuous and systematic capacity building, in the context of the continuously evolving and expanding immunisation program. in this context, we also recommend that countries should plan for and conduct EPI program reviews at least every 4-5 years, preferably timed to provide inputs into program plans along with setting up mechanisms to regularly monitor program performance and address gaps, as well as to follow up and implement recommendations from review exercises. These EPI reviews may not constitute an in-depth evaluation of all program components, indicating the need to tailor the implementation of the reviews towards specific aspects of the program, based on the country context and preliminary findings. In addition, as necessary, countries may plan to conduct in-depth evaluations, and root cause analyses.

What is known about this topic

  • Comprehensive national immunisation program reviews are conducted once every 4 to 5 years in low-and middle-income countries, in order to identify program areas for improvement, realign program focus as necessary and prepare the program for the introduction of additional program elements;
  • Comprehensive program reviews are complementary to reviews with in-depth focus on specific program components;
  • Recommendations generated by program reviews help countries to focus their efforts to address major program gaps.

What this study adds

  • With the rapid evolution of the scope and complexity of the immunisation programs across the region, countries should build in methods to regularly review program performance and develop their strategic directions with the required investments for program sustainability and also invest in capacity building;
  • A significant proportion of national immunisation programs in the sub-region continue to have gaps in their implementation of the reaching every district approach, in their human resource capacity, as well as in their logistics and data management systems;
  • The follow up of the review recommendations will be critical to address the identified system-wide barriers or gaps in order to strengthen the immunisation program and enable it to attain the objectives.

 

 

Competing interests Up    Down

The authors declare no competing interests.

 

 

Authors' contributions Up    Down

All the authors have read and agreed to the final manuscript.

 

 

Acknowledgments Up    Down

We would like to acknowledge the efforts of the national immunisation program staff, partners and stakeholders who took part in these extensive program reviews across the years. We thank the WHO immunisation program staff from the global, regional and sub-regional levels who coordinated the different reviews. We also thank Professor Tanimola Akande (University of Ibadan, Nigeria) and Mr. Stanley Diamenu(Ghana) for their valuable review of an early draft of the manuscript.

 

 

Tables  Up    Down

Table 1: period of latest National comprehensive EPI program review by country. Eastern and Southern Africa sub region (2012-2018)

Table 2: summary of findings on vaccine management and cold chain systems

Table 3: summary of findings on immunisation service delivery

Table 4: summary of findings on immunisation monitoring systems

Table 5: summary of findings on vaccine preventable diseases surveillance

 

 

References Up    Down

  1. Secretariat A, Report A, Global vaccine action plan, monitoring, evaluation & accountability secretariat annual report. Vaccine. 2018;31:B5-B31.

  2. WHO. Africa regional strategic plan for immunization 2014-2020. Accessed 24 December 2020.

  3. National Immunization Technical Advisory Group (ITAG). Guidance for their establishment and functioning. World Health Organization. 2008.

  4. Duclos P. National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening. Vaccine. 2010;28(Suppl 1):A18-A25. PubMed | Google Scholar

  5. Regulatory system strengthening for medical products. World Health Organization - Proceedings of the 67th World Health Assembly, 2014. 2014.

  6. WHO. Reaching Every District (RED)-A guide to increasing coverage and equity in all communities in the African Region. WHO Regional Office for Africa. Accessed 24 December 2020.

  7. WHO. WHO/UNICEF Joint Reporting Process. 2020. Accessed 24 December 2020.

  8. WHO. The immunization data quality audit (DQA) procedure World Health Organization Vaccines and Biologicals. 2003. Accessed 24 December 2020.

  9. WHO. A guide for conducting an Expanded Programme on Immunization ( EPI ) Review. WHO. 2017;87. Google Scholar

  10. Lyimo D, Kamugisha C, Yohana E, Eshetu M, Wallace A, Ward K et al. Improving the efficiency and standards of a national immunization program review: lessons learnt from United Republic of Tanzania. Pan Afr Med J. 2017 Nov 7;28:209. PubMed | Google Scholar

  11. GAVI. Joint Appraisal analysis guidance. 2020. Accessed 24 December 2020.

  12. WHO. Principles and considerations for adding a vaccine to a national immunization programme. 2015. Accessed 24 December 2020.

  13. Shen AK, Fields R, McQuestion M. The future of routine immunization in the developing world: challenges and opportunities. Global Health Science and Practice. 2014;2(4):381-394. PubMed | Google Scholar

  14. Dan. A USAID-Funded project administered by the partnership for child health care, INC, partners: academy for educational development immunization ICC. Immunization ICC the Immunization Inter-agency Coordination Committee Model example from DR Congo.

  15. Shaikh BT, Haq ZU, Tran N, Hafeez A. Health system barriers and levers in implementation of the expanded program on immunization (EPI) in Pakistan: an evidence informed situation analysis. Public Health Reviews. 2018;39:24. PubMed | Google Scholar

  16. Brown VB, Oluwatosin OA, Ogundeji MO. Impact of training intervention on immunization providers´ knowledge and practice of routine immunization in Ibadan, south-western Nigeria: a primary health care experience. Pan Afr Med J. 2017;26. Google Scholar

  17. Manyazewal T, Mekonnen A, Demelew T, Mengestu S, Abdu Y, Mammo D et al. Improving immunization capacity in Ethiopia through continuous quality improvement interventions: a prospective quasi-experimental study 11 Medical and Health Sciences 1117 Public Health and Health Services. Infectious Diseases of Poverty. 2018;7(1):119. Google Scholar

  18. Oku A, Oyo-Ita A, Glenton C, Fretheim A, Eteng G, Ames H et al. Factors affecting the implementation of childhood vaccination communication strategies in Nigeria: a qualitative study. BMC Public Health. 2017;17(1):200. PubMed | Google Scholar

  19. WHO. Expanded Programme on Immunization (EPI) and Vaccine Preventable Disease (VPD) Surveillance Review Regional Office for South-East Asia. Accessed 24 December 2020.

  20. Djibuti M, Gotsadze G, Zoidze A, Mataradze G, Esmail LC, Kohler J. The role of supportive supervision on immunization program outcome-a randomized field trial from Georgia. BMC Int Health Hum Rights. 2009;9(Suppl 1):S11. PubMed | Google Scholar

  21. Som M, Panda B, Pati S, Nallala S, Anasuya A, Chauhan AS ing et al. Effect of supportive supervision on routine immunization service delivery-a randomized post-test study in Odisha. Glob J Health Sci. 2014;6(6):61-67. PubMed | Google Scholar

  22. Lydon P, Schreiber B, Gasca A, Dumolard L, Urfer D, Senouci K. Vaccine stockouts around the world: are essential vaccines always available when needed. Vaccine. 2017;35(17):2121-2126. PubMed | Google Scholar

  23. LaFond A, Kanagat N, Steinglass R, Fields R, Sequeira J, Mookherji S. Drivers of routine immunization coverage improvement in Africa: findings from district-level case studies. Health Policy Plan. 2015 Apr;30(3):298-308. PubMed | Google Scholar

  24. Favin M, Steinglass R, Fields R, Banerjee K, Sawhney M. Why children are not vaccinated: a review of the grey literature. International Health. 2012;4(4):229-238. PubMed | Google Scholar

  25. Mihigo R, Okeibunor J, Anya B, Mkanda P, Zawaira F. Challenges of immunization in the African Region. Pan Afr Med J. 2017;27(Suppl 3):12. PubMed | Google Scholar

  26. Nnebue C, Onwasigwe C, Adinma E, Adogu PU. Challenges of data collection and disease notification in Anambra State, Nigeria. Trop J Med Res. 2017 Sep 26;17(1):746. Google Scholar

  27. Mandyata CB, Olowski LK, Mutale W. Challenges of implementing the integrated disease surveillance and response strategy in Zambia: a health worker perspective. BMC Public Health. 2017. PubMed | Google Scholar

  28. Cooper S, Betsch C, Sambala EZ, Mchiza N, Wiysonge CS. Vaccine hesitancy-a potential threat to the achievements of vaccination programmes in Africa. Human Vaccines and Immunotherapeutics. 2018;14(10):2355-2357. PubMed | Google Scholar

  29. Gerede R, Machekanyanga Z, Ndiaye S, Chindedza K, Chigodo C, Shibeshi ME et al. How to increase vaccination acceptance among apostolic communities: quantitative results from an assessment in three provinces in Zimbabwe. J Relig Health. 2017;56(5):1692-1700. PubMed | Google Scholar

  30. Jarrett C, Wilson R, O´Leary M, Eckersberger E, Larson HJ, Eskola J et al. Strategies for addressing vaccine hesitancy - a systematic review. Vaccine. 2015;33(34):4180-4190. PubMed | Google Scholar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research

Immunisation program reviews in East and Southern Africa. 2012-2018; key lessons

Research

Immunisation program reviews in East and Southern Africa. 2012-2018; key lessons

Research

Immunisation program reviews in East and Southern Africa. 2012-2018; key lessons